CHM
Click for more information
5.56% 1.9¢ chimeric therapeutics limited

Ann: Entitlement Offer to raise approximately $18.1 million, page-3

  1. Theman
    326 Posts.
    lightbulb Created with Sketch. 14
    clock Created with Sketch.
    21/02/22
    17:22
    Post #: 59713041
    Not really sure what there is to like about a 50% drop in the share price and then mass dilution.

    Too much spin from the CHM team on whether they needed additional funding.

    Why not wait for more results from the trials and then do a raise?

    Sorry very annoyed...
    Last edited by Theman: 21/02/22
    CHM Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.9¢ 		Change
0.001(5.56%) 		Mkt cap ! $16.39M
Open High Low Value Volume
1.9¢ 2.0¢ 1.8¢ $7.556K 401.3K

Buyers (Bids)

No. Vol. Price($)
4 354877 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 184613 2
View Market Depth
Last trade - 11.48am 27/06/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.